Literature DB >> 7862420

Prognostic factors of vision in patients with Behçet disease.

M Sakamoto1, K Akazawa, Y Nishioka, H Sanui, H Inomata, Y Nose.   

Abstract

BACKGROUND: Behçet disease is a chronic, recurrent, inflammatory disorder characterized by the triad of oral and genital ulcers and ocular lesions. The etiology is unknown. Although many of these patients become blind, some have good vision all their life.
METHODS: To attain more accurate data on the prognosis of these patients, the authors studied 52 Japanese patients (101 eyes) seen at Kyushu University Hospital between 1980 and 1990. At the first visit, patients ranged in age from 21 to 61 years; at onset, they ranged in age from 17 to 55 years; and the disease duration at first visit was from 0 to 22 years. Thirty-five of the 101 eyes had a visual loss of more than five lines or the patients became blind. The authors divided the subjects into two groups--favorable group and unfavorable group. If an eye had more than five lines of visual loss or the patient became blind 3 years after the first visit, it was placed in the unfavorable group, and if not, it was classed in the favorable group. Thirty-two factors determined from clinical records were used to select statistically significant risk factors for visual loss, using univariate analysis and multivariate logistic regression analysis.
RESULTS: Univariate analysis showed the following four factors that were significantly different between favorable and unfavorable groups: sex, disease interval, other complications, and skin lesions (first year). Multivariate analysis showed that the following seven factors had mutually independent contributions to visual loss: skin lesions; arthritis; posterior attacks; other complications (experienced), including gastrointestinal, vascular, and central nervous system lesions; female sex; disease interval; and anterior attacks. The first four factors have effects of losing vision, whereas the others are related to vision retention.
CONCLUSION: The authors find that skin lesions, arthritis, posterior attacks, and other complications are linked to loss of vision, whereas female sex, disease interval, and anterior attacks are related to retention of vision.

Entities:  

Mesh:

Year:  1995        PMID: 7862420     DOI: 10.1016/s0161-6420(95)31022-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  17 in total

1.  Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis.

Authors:  Allison R Loh; Nisha R Acharya
Journal:  Am J Ophthalmol       Date:  2010-10       Impact factor: 5.258

2.  Primary association of HLA-B51 with Behçet's disease in Ireland.

Authors:  D J Kilmartin; A Finch; R W Acheson
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

3.  Outcome of phacoemulsification in patients with uveitis.

Authors:  M A Elgohary; P J McCluskey; H M A Towler; N Okhravi; R P Singh; R Obikpo; S S Lightman
Journal:  Br J Ophthalmol       Date:  2007-01-17       Impact factor: 4.638

4.  Pattern of uveitis in Behçet's disease in a referral center in Tunisia, North Africa.

Authors:  Moncef Khairallah; Sonia Attia; Salim Ben Yahia; Salah Jenzeri; Rim Ghrissi; Bechir Jelliti; Sonia Zaouali; Riadh Messaoud
Journal:  Int Ophthalmol       Date:  2008-03-26       Impact factor: 2.031

Review 5.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

6.  Behçet's Uveitis.

Authors:  Ilknur Tugal-Tutkun
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

7.  Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity.

Authors:  R Oktay Kaçmaz; John H Kempen; Craig Newcomb; Sapna Gangaputra; Ebenezer Daniel; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; Douglas A Jabs; C Stephen Foster
Journal:  Am J Ophthalmol       Date:  2008-08-16       Impact factor: 5.258

8.  Ocular features of Behcet's disease: an international collaborative study.

Authors:  Nobuyoshi Kitaichi; Akiko Miyazaki; Daiju Iwata; Shigeaki Ohno; Miles R Stanford; Hormoz Chams
Journal:  Br J Ophthalmol       Date:  2007-12       Impact factor: 4.638

9.  Genital aphthosis in Behçet's disease: is it associated with less eye involvement?

Authors:  Seyedeh Tahereh Faezi; Cheyda Chams-Davatchi; S Zahra Ghodsi; Farhad Shahram; Abdolhadi Nadji; Massoomeh Akhlaghi; Kamran Moradi; Pedram Paragomi; Golnaz Ghazizadeh Esslami; Bahar Sadeghi Abdollahi; Farimah Ashofteh; Fereydoun Davatchi
Journal:  Rheumatol Int       Date:  2014-04-12       Impact factor: 2.631

10.  Behçet's disease: comparing 3 decades of treatment response at the National Eye Institute.

Authors:  Leila I Kump; Kristy L Moeller; George F Reed; Shree K Kurup; Robert B Nussenblatt; Grace A Levy-Clarke
Journal:  Can J Ophthalmol       Date:  2008-08       Impact factor: 1.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.